Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neville F Hacker

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 4, 2012
Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and AustralasiaW Glenn McCluggage, Terry Colgan, Maire Duggan, et al.
Molecular Cancer|January 8, 2014
ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancerBrian Gloss, Kim Moran-Jones, Vita Lin, et al.
International Journal of Molecular Medicine|February 19, 2014
A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic markerViola A Heinzelmann-Schwarz, Sheri Nixdorf, Mehrnaz Valadan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2011
TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinomaGoli Samimi, Brian Z Ring, Doug T Ross, et al.
Molecular Oncology|August 31, 2017
Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinomaMerrina Anugraham, Francis Jacob, Arun V Everest-Dass, et al.
Journal of Cancer Research and Clinical Oncology|January 30, 2020
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?Viola Heinzelmann-Schwarz, André B Kind, Marcus Vetter, et al.
Cancer Letters|December 14, 2011
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkersBrian S Gloss, Kate I Patterson, Caroline A Barton, et al.
Cancer Research|February 12, 2004
Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell lineSvetlana D Pack, Ozgül M Alper, Kurt Stromberg, et al.
Cancer Epidemiology|May 26, 2015
Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilitiesYoon-Jung Kang, Dianne L O'Connell, Jeffrey Tan, et al.
BMC Genomics|June 16, 2014
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaKristina Warton, Vita Lin, Tina Navin, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 4, 2012
Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and AustralasiaW Glenn McCluggage, Terry Colgan, Maire Duggan, et al.
Molecular Cancer|January 8, 2014
ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancerBrian Gloss, Kim Moran-Jones, Vita Lin, et al.
International Journal of Molecular Medicine|February 19, 2014
A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic markerViola A Heinzelmann-Schwarz, Sheri Nixdorf, Mehrnaz Valadan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2011
TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinomaGoli Samimi, Brian Z Ring, Doug T Ross, et al.
Molecular Oncology|August 31, 2017
Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinomaMerrina Anugraham, Francis Jacob, Arun V Everest-Dass, et al.
Journal of Cancer Research and Clinical Oncology|January 30, 2020
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?Viola Heinzelmann-Schwarz, André B Kind, Marcus Vetter, et al.
Cancer Letters|December 14, 2011
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkersBrian S Gloss, Kate I Patterson, Caroline A Barton, et al.
Cancer Research|February 12, 2004
Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell lineSvetlana D Pack, Ozgül M Alper, Kurt Stromberg, et al.
Cancer Epidemiology|May 26, 2015
Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilitiesYoon-Jung Kang, Dianne L O'Connell, Jeffrey Tan, et al.
BMC Genomics|June 16, 2014
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaKristina Warton, Vita Lin, Tina Navin, et al.
Pageof 7